Background Polycystic ovary syndrome (PCOS) is characterised by infrequent or absent
ovulation, and high levels of androgens and insulin (hyperinsulinaemia). Hyperinsulinaemia …

Obesity, particularly the abdominal phenotype, is associated with several reproductive
disturbances. Whereas mechanisms by which obesity affect fertility are complex and still not …

Polycystic ovarian syndrome (PCOS) affects 4% to 12% of women of reproductive age. The
lack of well-defined diagnostic criteria makes identification of this common disease …

Metformin, a biguanide, has been available in the US for the treatment of type 2 diabetes
mellitus for nearly 8 years. Over this period of time, it has become the most widely prescribed …

Polycystic ovary syndrome (PCOS) is a medical condition that has brought multiple
specialists together. Gynecologists, endocrinologists, cardiologists, pediatricians, and …

BACKGROUND: Anti-Müllerian hormone (AMH) is secreted by granulosa cells of ovarian
early developing follicles and its serum levels have been shown to correlate with small …

Objective: To determine whether metformin treatment increases the ovulation and
pregnancy rates in response to clomiphene citrate (CC) in women who are resistant to CC …

Objective: Unknown etiology Background: Anovulation consists in the lack of oocyte release
during the menstrual cycle, leading to an irregular menstrual cycle. Untreated chronic …

OBJECTIVE: To determine whether insulin-sensitizing drugs would improve ovulation and T
levels in women with polycystic ovary syndrome (PCOS), without clinical or biochemical …

Use of metformin in polycystic ovary syndrome (PCOS) is becoming increasingly accepted
and widespread, but clinical practice is ahead of the evidence. Although a wide range of …